Russia begins testing a new drug against coronavirus. According to the head of the Gamaleya Center Alexander Gunzburg, it’s about medicine based on monoclonal antibodies.
According to him, the development may appear on the market towards the end of spring – after the first two phases of clinical tests are completed, the TV channel reports. “Russia 24”. But the fact that the drug is effective is already known, it showed a high potential at the stage of preliminary studies.
Gunzburg also said that new nasal vaccine from covid will be two-component. In the case of revaccination, a single application is sufficient.
Preventive measures are being tightened in the Russian regions to combat the coronavirus. So, in the Ulyanovsk region, Rospotrebnador introduced mandatory vaccination for residents over 60 years old. In the region, there are too few vaccinated among the elderly, the disease among them can spread quickly, especially in the case of the Omicron strain.
The Russian Direct Investment Fund reports: the drug “Sputnik V” well neutralizes a new type of coronavirus. They also said that they had applied in India for the approval of the vaccine. “Sputnik M” for teenagers.
According to the operational headquarters, published the day before, more than 27 thousand infected with covid were detected in Russia over the past day. About 26.5 thousand have recovered.
.
ttn-20